Time flies and this year PhRMA (Pharmaceutical Research and Manufacturers of America) marks 16 years since the code on interactions with healthcare professionals took effect and the updated code in January 2009. The The European Federation of Pharmaceutical Industries and Associations consolidates its final version in 2013 which was approved by the General Assembly on June 6th 2014. Nevertheless, EFPIA’s Disclosure Code commenced in 2016 tightening disclosure requirements on sponsorship of HCPs by pharma companies. In October of 2016, the Association of British Healthcare Industries (ABHI) alongside 250 company members announced considerable changes to its code. Medtech Europe later on introduced its new Ethical Code of Business Practice and actually launched on July 4th 2018.
“Changing compliance codes in Europe regulating medical-device companies are expected to have major effect on U.S.-based medical conferences ─ and to continue to do so for years to come” says Patricia Andrade, VP Marketing and Communications at ATBS Convention Service, making it the first meetings and events company in the US to be certified by Medtech Europe Ethical Charter.
Both associations’ commitment to following the highest ethical standards as well as all legal requirements has provided a greater transparency among the industry, HCOs and HCPs. Despite the fact that it has enhanced the practice of medicine, in turn pharmaceuticals resources have become limited. To ensure product accessibility to patients for a maximum benefit, appropriate marketing must be pursued the follow.
So what are today’s CHALLENGES for pharma marketers facing digital healthcare?
2018 digital health beneficial OPPORTUNITIES for pharma marketers:
A Universal Peer-to-Peer Social Network
Over the past six years, G-Med has become the largest global medical community to more than 120,000 physicians from 50 countries and 60 specialties. With digital healthcare constantly evolving, it is important for G-Med to leverage the power of social media. A unique platform where physicians from around the world can share and present patient cases, collaborate to improve and increase practiced methods, peer-to-peer discussions of new legislation, research and analyze qualified medical data.
According to a Medical Marketing & Media (MM&M) research 54% of physicians (surveyed) restrict access to pharma sales representatives, while 80% of all physicians were accessible seven years ago. It also found that about 74% of physicians use at least one channel to interact with pharma and 59% of those polled spend 1–5 hours per week on digital channels who reported that social media improved the quality in patients’ treatment.
Although the industry as a whole may be taking baby-steps towards digital communications and social media, new surveys showed that physicians who are connected to qualified peers are more likely to adopt new treatments and medical solutions. Today social media offers valuable advantages enabling HCPs to present, share, discuss and analyze patient cases to achieve best practices, or even develop medical solutions.
G-Med ─ Solving Challenges and Providing Opportunities for Global Digital Pharma Marketers
PEER-TO-PEER DISCUSSION GROUPS
All of G-Med's digital tools for healthcare marketers are enhanced by the power of the online community. From basic promotional marketing tools to peer to peer discussion groups, our solutions excel at influence physicians.
Pharma Marketers, for more information please visit https://www.g-med.info/pharma-marketers
Physicians, for more information please visit https://www.g-med.info